The Rocky Mountain Life Science Investor & Partnering Conference(RMLIPC) will bring together leading investors and strategic partners from across the U.S. and the region’s top life science companies to cultivate partnerships and source investment opportunities in the areas of medical device, diagnostic, biotech, pharma and digital health.

The Rocky Mountain region is the largest and most advanced area between both coasts, with over $1.9 billion in investment in the region between 2011-2016.

cliexa is selected as one of the presenting companies by Colorado BioScience Association‘s at Rocky Mountain Life Science Investor and Partnering Conference.

April Bohnert told our story at BuiltinColorado’s article.

Cliexa, based in Colorado, has developed chronic condition management apps. It’s a graduate of the
Boulder, Colo.-based Boomtown Accelerator and has developed its product in partnership with Kaiser Permanente.

Read more at Maine Startup Insider Article here.

Portland-based business accelerator Venture Hall has announced the seven early-stage startup companies to be included in the inaugural class of its summer accelerator program.

Read more at Press Herald’s article.

cliexa’s Rheumatoid Arthritis App scores as the 2nd best RA app out of more than 900 Tested.

cliexa-RA, Cliexa’s rheumatoid arthritis app, has been scored as the 2nd best RA app among 19 best apps selected from 900+ apps to NIH research.

Read more at Colorado BioScience Association website.